Skip to main content

Table 6 Radiotherapy dose and survival in definitive RT (n = 9)

From: A 10-year clinical outcome of radiotherapy as an adjuvant or definitive treatment for primary tracheal adenoid cystic carcinoma

 

EBRT alone (low-dose)

EBRT + BT boost (high-dose)

p-value

No. of patients

3

6

 

RT dose (Gy)

   

 Median

66.0

77.1

 

 Range

66.0–70.2

70.8–80.0

 

5-yr. LPFS (%)

0.0

100.0

.002

5-yr. OS (%)

33.3

83.3

.036

  1. RT: radiotherapy, EBRT external-beam RT, BT brachytherapy, LPFS local-progression free survival, OS overall survival